Literature DB >> 31869561

[Prevalence of diabetes and poor glycemic control in Mexico: results from Ensanut 2016.]

Ana Basto-Abreu1, Tonatiuh Barrientos-Gutiérrez1, Rosalba Rojas-Martínez1, Carlos A Aguilar-Salinas2, Nancy López-Olmedo1, Vanessa De la Cruz-Góngora3, Juan Rivera-Dommarco4, Teresa Shamah-Levy3, Martín Romero-Martínez3, Simón Barquera5, Ruy López-Ridaura6, Mauricio Hernández-Ávila7, Salvador Villalpando.   

Abstract

OBJECTIVE: To estimate the prevalence of total, diagnosed and undiagnosed diabetes, and the prevalence of poor glycemic control in Mexico, and its associated factors.
MATERIALS AND METHODS: Data from 3 700 adult participants were analysed in the 2016 National Health and Nutrition Survey. Diabetes prevalences were estimated with population weights, and the factors associated with total diabetes and poor glycemic control with Poisson regression models.
RESULTS: The total prevalence of diabetes was 13.7% (9.5% diagnosed, 4.1% undiagnosed); 68.2% of people with diagnosed diabetes presented poor glycemic control. Longer disease duration, living in the centre or south of the country and being treated in pharmacies were associated with poor glycemic control. Being treated in a social security system was associated with better glycemic control.
CONCLUSIONS: Multisectoral efforts are needed to strengthen screening, timely diagnosis and disease control, considering differences by region and type of health service.

Entities:  

Keywords:  diabetes mellitus type 2; epidemiologic surveys; glycemia; prevalence

Mesh:

Substances:

Year:  2020        PMID: 31869561     DOI: 10.21149/10752

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  22 in total

Review 1.  Multimorbidity matters in low and middle-income countries.

Authors:  Ana Basto-Abreu; Tonatiuh Barrientos-Gutierrez; Alisha N Wade; Daniela Oliveira de Melo; Ana S Semeão de Souza; Bruno P Nunes; Arokiasamy Perianayagam; Maoyi Tian; Lijing L Yan; Arpita Ghosh; J Jaime Miranda
Journal:  J Multimorb Comorb       Date:  2022-06-16

2.  Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America.

Authors:  Pablo F Belaunzaran-Zamudio; Yanink Caro-Vega; Mark J Giganti; Jessica L Castilho; Brenda E Crabtree-Ramirez; Bryan E Shepherd; Fernando Mejía; Carina Cesar; Rodrigo C Moreira; Marcelo Wolff; Jean W Pape; Denis Padgett; Catherine C McGowan; Juan G Sierra-Madero
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

3.  Non-communicable diseases and inequalities increase risk of death among COVID-19 patients in Mexico.

Authors:  Juan Pablo Gutierrez; Stefano M Bertozzi
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

Review 4.  Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent.

Authors:  M Larissa Avilés-Santa; Alberto Monroig-Rivera; Alvin Soto-Soto; Nangel M Lindberg
Journal:  Curr Diab Rep       Date:  2020-10-10       Impact factor: 4.810

5.  Longitudinal changes in the retail food environment in Mexico and their association with diabetes.

Authors:  Carolina Pérez-Ferrer; Amy H Auchincloss; Tonatiuh Barrientos-Gutierrez; M Arantxa Colchero; Leticia de Oliveira Cardoso; Mariana Carvalho de Menezes; Usama Bilal
Journal:  Health Place       Date:  2020-10-09       Impact factor: 4.078

6.  In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation.

Authors:  Antonio Olivas-Martínez; José Luis Cárdenas-Fragoso; José Víctor Jiménez; Oscar Arturo Lozano-Cruz; Edgar Ortiz-Brizuela; Víctor Hugo Tovar-Méndez; Carla Medrano-Borromeo; Alejandra Martínez-Valenzuela; Carla Marina Román-Montes; Bernardo Martínez-Guerra; María Fernanda González-Lara; Thierry Hernandez-Gilsoul; Alfonso Gulias Herrero; Karla María Tamez-Flores; Eric Ochoa-Hein; Alfredo Ponce-de-León; Arturo Galindo-Fraga; David Kershenobich-Stalnikowitz; José Sifuentes-Osornio
Journal:  PLoS One       Date:  2021-02-03       Impact factor: 3.240

7.  High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients.

Authors:  Estefanía Alcántara-Alonso; Fernando Molinar-Ramos; Jesús Alberto González-López; Viridiana Alcántara-Alonso; Marco Antonio Muñoz-Pérez; José Juan Lozano-Nuevo; Daniel Rabindranath Benítez-Maldonado; Elizabeth Mendoza-Portillo
Journal:  Clin Nutr ESPEN       Date:  2021-05-07

8.  Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach.

Authors:  Omar Yaxmehen Bello-Chavolla; Jessica Paola Bahena-López; Arsenio Vargas-Vázquez; Neftali Eduardo Antonio-Villa; Alejandro Márquez-Salinas; Carlos A Fermín-Martínez; Rosalba Rojas; Roopa Mehta; Ivette Cruz-Bautista; Sergio Hernández-Jiménez; Ana Cristina García-Ulloa; Paloma Almeda-Valdes; Carlos Alberto Aguilar-Salinas
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

9.  High Mortality Among Health Personnel With COVID-19 in Mexico.

Authors:  Irving Armando Domínguez-Varela
Journal:  Disaster Med Public Health Prep       Date:  2020-10-13       Impact factor: 1.385

10.  Changes in the Diagnosis and Management of Diabetes in Mexico City Between 1998-2004 and 2015-2019.

Authors:  Diego Aguilar-Ramirez; Jesus Alegre-Díaz; Louisa Gnatiuc; Raúl Ramirez-Reyes; Rachel Wade; Michael Hill; Rory Collins; Richard Peto; Jonathan R Emberson; William G Herrington; Pablo Kuri-Morales; Roberto Tapia-Conyer
Journal:  Diabetes Care       Date:  2021-02-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.